胰腺切除术后高淀粉酶血症与术后急性胰腺炎的临床意义:系统综述与荟萃分析
结果显示两者均与术后胰瘘等并发症增加相关,PPAP还与大出血、胃排空延迟、Clavien-Dindo IIIa级及以上并发症、死亡及住院时间延长相关。
要点
- 术后高淀粉酶血症与术后胰瘘风险升高相关
- PPAP与胰瘘、出血、胃排空延迟及严重并发症相关
- 采用ISGPS定义可早期识别高危患者
核心结论
- 本荟萃分析提示,胰腺切除术后高淀粉酶血症与PPAP均与术后并发症增加相关。
- 在临床实践中采用上述定义,可通过早期分层识别并发症高风险患者。
研究设计与样本
- 系统综述与荟萃分析,检索PubMed、EMBASE和Cochrane Library数据库。
- 采用Mantel-Haenszel随机效应模型计算风险比及95%置信区间。
主要发现
- 术后高淀粉酶血症与术后胰瘘率升高相关(风险比0.33,95%CI 0.21-0.51,P<.001)。
- PPAP与术后胰瘘相关(风险比0.24,95%CI 0.17-0.35,P<.001)。
- PPAP与术后胰腺出血相关(风险比0.39,95%CI 0.26-0.59,P<.001)。
- PPAP与胃排空延迟相关(风险比0.57,95%CI 0.41-0.79,P=.007)。
- PPAP与Clavien-Dindo IIIa级及以上并发症(风险比0.38,95%CI 0.25-0.58,P<.001)、死亡(风险比0.42,95%CI 0.27-0.65,P=.001)及住院时间延长(均数差-7.76天,95%CI -12.52至3.00,P=.001)相关。
关键数值与推荐
- 术后高淀粉酶血症与术后胰瘘相关:风险比0.33(95%CI 0.21-0.51,P<.001)。
- PPAP与术后胰瘘相关:风险比0.24(95%CI 0.17-0.35,P<.001)。
- PPAP与术后胰腺出血相关:风险比0.39(95%CI 0.26-0.59,P<.001)。
- PPAP与胃排空延迟相关:风险比0.57(95%CI 0.41-0.79,P=.007)。
- PPAP与Clavien-Dindo IIIa级及以上并发症、死亡及住院时间延长相关,对应风险比分别为0.38、0.42,均数差-7.76天。
临床怎么用
- 对胰腺切除术后患者按ISGPS定义评估术后高淀粉酶血症与PPAP,以早期识别并发症高风险者。
- 对存在术后高淀粉酶血症或PPAP的患者加强术后监测,警惕胰瘘、出血、胃排空延迟等并发症。
局限性
- 本文未报告纳入研究的异质性、发表偏倚及具体样本量等局限性信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Since its definition in 2022, postpancreatectomy acute pancreatitis has been increasingly recognized as a critical postoperative entity, but its clinical significance has not been evaluated through systematic review and meta-analysis. The aim of current study was to evaluate the clinical implications of postoperative hyperamylasemia and postpancreatectomy acute pancreatitis according to the International Study Group for Pancreatic Surgery consensus definition. METHODS: A systematic review with meta-analysis was conducted in PubMed, EMBASE, and Cochrane Library databases. Studies published between January 2022 and August 2024 that used the International Study Group for Pancreatic Surgery definitions for postoperative hyperamylasemia and postpancreatectomy acute pancreatitis were included. Risk ratios with 95% confidence intervals were calculated using a Mantel-Haenszel random-effects model. RESULTS: Eleven studies were included in the meta-analysis. Postoperative hyperamylasemia was associated with increased postoperative pancreatic fistula rates (risk ratio, 0.33; 95% confidence interval, 0.21-0.51; P < .001). Postpancreatectomy acute pancreatitis was associated with greater rates of postoperative pancreatic fistula (risk ratio, 0.24; 95% confidence interval, 0.17-0.35; P < .001), postoperative pancreatic hemorrhage (risk ratio, 0.39; 95% confidence interval, 0.26-0.59; P < .001), delayed gastric emptying (risk ratio, 0.57; 95% confidence interval, 0.41-0.79; P = .007), Clavien-Dindo classification IIIa or greater complications (risk ratio, 0.38; 95% confidence interval, 0.25-0.58; P < .001), mortality (risk ratio, 0.42; 95% confidence interval, 0.27-0.65; P = .001), and longer hospital stays (mean difference, -7.76 days; 95% confidence interval, -12.52 to 3.00; P = .001). CONCLUSION: This first meta-analysis exploring their clinical significance demonstrates that both postoperative hyperamylasemia and postpancreatectomy acute pancreatitis are associated with increased postoperative complications after pancreatectomy. The adoption of these definitions in clinical practice could significantly impact the postoperative course by early stratifying patients at higher risk for additional morbidity.
引用
- Heo D, Cardoso SA, Cardoso RP, et al. Clinical implications of postoperative hyperamylasemia and postpancreatectomy acute pancreatitis after pancreatectomy: A systematic review and meta-analysis. Surgery. 2025. PMID: 40435914. doi:10.1016/j.surg.2025.109443
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。